Arkopharma Arkocápsulas Harpagocito 435 mg is a natural supplement made from Harpagocito root extract, known for its anti-inflammatory and analgesic properties. Designed to relieve joint and muscle discomfort, it promotes mobility and osteoarticular well-being. Perfect for a healthy and active lifestyle.
Precio: €26.28
Arkopharma Arkocápsulas Harpagocito 435 Mg 168 Capsules
Composition
- Per capsule: 435 mg of cryo-ground roots of Harpagophytum procumbens.
Indications
- MUSCULOSKELETAL PAIN. Treatment of mild joint pain.
Its use is based exclusively on traditional use.
Dosage
- Adults, oral: 1 capsule with three meals, for 1 month. Treatment can be prolonged for one month.
- Children and adolescents under 18 years of age, oral: Safety and efficacy have not been evaluated.
Guidelines for proper administration
It is advisable to take devil's claw with meals.
Contraindications
- Hypersensitivity to devil's claw or to any component of the medicinal product.
- PEPTIC ULCER]. Patients with active peptic ulcer should avoid the use of harpagofito, due to the risk of aggravation of the ulceration, and therefore, gastric haemorrhage and perforation.
Precautions
- History of peptic ulcer. There are no reports of peptic ulcer and/or gastric haemorrhage following the use of harpagophytum, although some authors claim that it could cause gastric damage. Therefore, extreme caution is advised in patients who have previously had peptic ulcers. If symptoms of gastroduodenal erosion such as [Nausea], [VOMITING], [GASTRIC HYPERACTION] or [ABDOMINAL PAIN] in the epigastric area are observed, it is recommended to discontinue the administration of devil's claw.
- Cardiovascular diseases, such as [ARTERIAL HYPERTENSION] or [HYPOTENSION]. Some authors warn of the risk of cardioactive effects of devil's claw, which could affect blood pressure. Caution is therefore advised in these patients.
- Joint inflammation. If joint pain is accompanied by joint swelling, redness or fever, it is advisable to consult a doctor, as this may mask more serious injuries.
Patient advice
- If symptoms continue or worsen during the use of devil's claw, it is recommended to consult a doctor or pharmacist.
- If joint pain is accompanied by joint swelling, redness or fever, a doctor should be consulted.
Special warnings
- Patients complaining of joint swelling, redness or fever should be evaluated.
Pregnancy
There are some reports of a possible oxytocic effect of devil's claw, although there is no data to confirm this statement. There are no adequate and well-controlled studies in humans, so devil's claw should not be used except in situations where the benefits outweigh the possible risks in the absence of safer therapeutic alternatives.
Breastfeeding
It is not known whether the components of devil's claw are excreted in breast milk, and the possible effects that this excretion could have on the infant. It is advisable to avoid the use of devil's claw during lactation, and if necessary, to discontinue breast-feeding.
Children
Safety and efficacy in children and adolescents under 18 years of age have not been evaluated and therefore it is recommended to avoid its use.
Elderly
No specific problems have been reported in the elderly.
Adverse reactions
- Digestive: [NAUSEA] and [VOMITING], [ABDOMINAL PAIN] and [DIARRHEA].
- Neurological/psychological: [HEADACHE] and [DIZZINESS].
- Allergic/dermatological: [HYPERSENSITIVITY REACTIONS] of dermatological nature.
Overdosage
Symptoms: No cases of overdose have been reported.Treatment: In case of overdose it is advisable to discontinue the administration of harpagofito, and to proceed with symptomatic treatment.
